Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relative glucocorticoid potency revisited

H Tanaka1, F Hirano, Y Nomura

  • 1Second Department of Internal Medicine, Asahikawa Medical College, Japan.

Rheumatology International
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paper-based graphene bioelectrode enabling third-generation fructose dehydrogenase sensing of inulin.

Biosensors & bioelectronics·2025
Same author

Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of <i>TNFAIP3</i>, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2020
Same author

Nuclear factor-κB regulates RANTES chemokine expression in response to tumor necrosis factor-α in fibroblast-like synoviocytes.

Modern rheumatology·2014
Same author

The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells.

Scandinavian journal of rheumatology·2006
Same author

Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts.

Annals of the rheumatic diseases·2002
Same author

Bile acids regulate RANTES gene expression through its cognate NF-kappaB binding sites.

Biochemical and biophysical research communications·2001
Same journal

Axial gout diagnosed by dual-energy CT in a young normouricaemic man with recurrent nephrolithiasis: a case-based review.

Rheumatology international·2026
Same journal

Psoriatic arthritis patients have increased morbidity already at the time of diagnosis: a case-control study.

Rheumatology international·2026
Same journal

VEXAS syndrome unmasked from relapsing polychondritis and infection mimicry: a case-based review.

Rheumatology international·2026
Same journal

Myocarditis as the first sign of SLE: a case report and review of the literature.

Rheumatology international·2026
Same journal

Infrared thermography of the tongue in systemic lupus erythematosus: a pilot study of thermal response to cold stimulation.

Rheumatology international·2026
Same journal

Pre-referral laboratory completeness and diagnostic yield in an early arthritis clinic: a retrospective single-centre analysis.

Rheumatology international·2026
See all related articles

This study introduces a new transcription assay to measure the potency of glucocorticoids. The assay effectively ranks synthetic and natural glucocorticoids like dexamethasone and cortisol by their ability to induce gene expression.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Endocrinology

Background:

  • Glucocorticoids are vital hormones with diverse physiological roles.
  • Assessing the relative potency of different glucocorticoid compounds is crucial for therapeutic applications.
  • Existing methods for potency assessment can be complex or time-consuming.

Purpose of the Study:

  • To develop and validate a novel transcription-based assay for determining the relative potency of synthetic and natural glucocorticoids.
  • To compare the potency of commonly used glucocorticoids, including dexamethasone, prednisolone, and cortisol.

Main Methods:

  • Cells expressing the glucocorticoid receptor were transfected with a hormone-inducible reporter gene.
  • The reporter gene's expression, indicative of hormonal activity, was quantified using a chloramphenicol acetyltransferase assay.

Related Experiment Videos

  • Various glucocorticoid ligands were tested in a dose-dependent manner.

    • Main Results:

    • Dexamethasone, prednisolone, and cortisol all demonstrated dose-dependent induction of reporter gene expression.
    • The transcription assay provided a quantitative measure of relative ligand potency.
    • A clear order of potency was established among the tested glucocorticoids.

    Conclusions:

    • The developed transcription assay offers a convenient and alternative method for evaluating glucocorticoid relative potency.
    • This assay facilitates efficient comparison of different glucocorticoid compounds.
    • The findings support the utility of this assay in pharmacological and endocrinological research.